LENZ Therapeutics, Inc.
LENZ
$29.83
$0.953.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 28.87% | -9.16% | -- | -- | -- |
| Total Depreciation and Amortization | 286.67% | 164.29% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,992.64% | 267.25% | -- | -- | -- |
| Change in Net Operating Assets | -239.12% | -267.54% | -- | -- | -- |
| Cash from Operations | 1.64% | -52.08% | -- | -- | -- |
| Capital Expenditure | -1,460.00% | -866.67% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -420.47% | -183.99% | -- | -- | -- |
| Cash from Investing | -421.52% | -184.49% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 41,132.02% | 38,270.64% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4,757.16% | 20,089.44% | -- | -- | -- |
| Cash from Financing | 146.59% | 91.55% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.85% | -115.08% | -- | -- | -- |